Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

January 24, 2024

Conditions
Pancreatic Ductal AdenocarcinomaPancreatitis, ChronicPancreatic Neuroendocrine TumorAutoimmune Pancreatitis
Interventions
DIAGNOSTIC_TEST

EUS-AI model

The test subset (approximately 20% of total patients) is reserved for the final evaluation of the EUS-AI model. Clinical parameters and EUS pictures of each patient in the test subset will be inputed into the trained EUS-AI model, and the most possible diagnosis will be given by the model.

Trial Locations (1)

430030

Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

LanZhou University

OTHER

lead

Huazhong University of Science and Technology

OTHER